rxstat › Shortages › Dapagliflozin Metformin
Dapagliflozin Metformin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Dapagliflozin Metformin products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 24, 2026.
In shortage since
Apr 28, 2026
Est. full return
Jul 24, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-DAPAGLIFLOZIN-METFORMIN
5MG
1000MG · TABLET · APOTEX INC
DIN 02536161 · since Jun 16, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-DAPAGLIFLOZIN-METFORMIN
5MG
850MG · TABLET · APOTEX INC
DIN 02536153 · since May 4, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-DAPAGLIFLOZIN-METFORMIN
1000MG
5MG · TABLET · APOTEX INC
DIN 02536161 · since Apr 28, 2026, est. end May 22, 2026 · Disruption of the manufacture of the drug.
AnticipatedAPO-DAPAGLIFLOZIN-METFORMIN
1000MG
5MG · TABLET · APOTEX INC
DIN 02536161 · Disruption of the manufacture of the drug.
AnticipatedAPO-DAPAGLIFLOZIN-METFORMIN
5MG
850MG · TABLET · APOTEX INC
DIN 02536153 · Disruption of the manufacture of the drug.
ResolvedAURO-DAPAGLIFLOZIN / METFORMIN
5MG
1000MG · TABLET · AURO PHARMA INC
DIN 02533081 · ended Apr 14, 2026 · Requirements related to complying with good manufacturing practices.
ResolvedAURO-DAPAGLIFLOZIN / METFORMIN
850MG
5MG · TABLET · AURO PHARMA INC
DIN 02533073 · ended Jan 28, 2025 · Demand increase for the drug.
ResolvedAURO-DAPAGLIFLOZIN / METFORMIN
1000MG
5MG · TABLET · AURO PHARMA INC
DIN 02533081 · ended Jan 28, 2025 · Demand increase for the drug.
ResolvedAPO-DAPAGLIFLOZIN-METFORMIN
850MG
5MG · TABLET · APOTEX INC
DIN 02536153 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-DAPAGLIFLOZIN-METFORMIN
1000MG
5MG · TABLET · APOTEX INC
DIN 02536161 · ended Aug 1, 2024 · Disruption of the manufacture of the drug.
ResolvedXIGDUO
850MG
5MG · TABLET · ASTRAZENECA CANADA INC
DIN 02449935 · ended Feb 22, 2022 · Delay in shipping of the drug.
ResolvedXIGDUO
1000MG
5MG · TABLET · ASTRAZENECA CANADA INC
DIN 02449943 · ended Apr 12, 2019 · Demand increase for the drug.
What's happening
Dapagliflozin Metformin is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Dapagliflozin Metformin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).
Recent changes
Common questions
When will Dapagliflozin Metformin be back in stock in Canada?
The latest manufacturer estimate is Jul 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Dapagliflozin Metformin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All blood glucose lowering drugs, excl. insulins shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.